Antisense oligonucleotides (ASOs) are recognized as promising therapeutic agents for central nervous system (CNS) diseases. However, neurotoxicity induced by ASOs via intrathecal administration poses a major limitation for clinical use....
Katsuyama et al. (Wed,) studied this question.